Integrative analysis of genome-wide DNA methylation and gene expression profiles associated with incident chronic kidney disease: the longitudinal Pros-RODAM cohort study

BACKGROUND: Chronic kidney disease (CKD) is increasing rapidly in African populations, yet its molecular determinants remain poorly characterised. While epigenome-wide studies have been largely confined to high-income settings, comparable longitudinal epigenetic data from African populations are scarce, despite distinct genetic and environmental contexts. We conducted a longitudinal epigenome-wide study of CKD in an African population, integrating DNA methylation and gene expression to identify epigenetic changes associated with CKD and related kidney function decline. METHODS: DNA methylation was profiled using the Illumina EPIC (850K) array in 274 Ghanaian participants from the RODAM-Prospective cohort (92 incident CKD cases and 182 matched controls), providing 548 DNA methylation observations across baseline and ∼6-year follow-up, with high-quality DNA methylation data available at both timepoints. Epigenome-wide association studies (EWAS) were performed for incident CKD, change in estimated glomerular filtration rate (ΔeGFR), and change in urinary albumin-to-creatinine ratio (ΔACR), adjusting for demographic, clinical, and technical covariates. Differentially methylated regions (DMRs) were identified using bumphunter with family-wise error rate control. Differential gene expression (RNA-seq) analyses were conducted, followed by covariate-adjusted expression quantitative trait methylation (eQTM) analyses to link methylation with gene expression. FINDINGS: At baseline, significant differentially methylated positions (DMPs) were detected at INF2 (incident CKD), CLIP4 (ΔeGFR), and TMEM109 (ΔACR), alongside DMRs at HLA-DPB1 and SH2D1B (incident CKD) and ZFP57 and OR2T11 (ΔACR). At follow-up, a progression-related DMR in C4orf39/TRIM61 (ΔACR) was identified, with recurrent signals at hypermethylated HLA-DPB1 and hypomethylated ZFP57 and OR2T11 across timepoints. Integrative eQTM analysis revealed methylation-expression associations at recurrent loci including ZFP57, HLA-DRB5, SLC39A4, and SPATC1L, with predominantly inverse associations at ZFP57, HLA-DRB5, and SLC39A4, highlighting associations with metabolic and immune regulatory pathways. INTERPRETATION: We identified epigenetic changes associated with incident CKD and kidney function decline in an African population. These methylation signals, supported by gene expression patterns, highlight immune and kidney-related pathways associated with CKD risk and progression. Our findings provide a foundation for future studies investigating the potential of epigenetic markers in CKD risk stratification and prevention in African populations. FUNDING: European Commission; European Research Council.

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2026-11-13
DOI
https://doi.org/10.1016/j.ebiom.2026.106542
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrative analysis of genome-wide DNA methylation and gene expression profiles associated with incident chronic kidney disease: the longitudinal Pros-RODAM cohort study

Benedicta Ngwenchi Nkeh-Chungag, Charles Frederick Hayfron-Benjamin, Samuel Nkansah Darko, Constance Rufaro Sewani-Rusike et al.
2 links
EBioMedicine
Epigenetics and DNA Methylation
article

Integrative analysis of genome-wide DNA methylation and gene expression profiles associated with incident chronic kidney disease: the longitudinal Pros-RODAM cohort study

Benedicta Ngwenchi Nkeh-Chungag, Charles Frederick Hayfron-Benjamin, Samuel Nkansah Darko, Constance Rufaro Sewani-Rusike, Felix Patience Chilunga, Liffert Vogt, Muhau Muhulo Mungamba, Peter Henneman, Charles O Agyemang, Eva L. van der Linden, manasa Kalya Purushothama, Karlijn A. C. Meeks, Andrea Venema, Ellis Owusu-Dabo, Bert-Jan van den Born
article en

Abstract

BACKGROUND: Chronic kidney disease (CKD) is increasing rapidly in African populations, yet its molecular determinants remain poorly characterised. While epigenome-wide studies have been largely confined to high-income settings, comparable longitudinal epigenetic data from African populations are scarce, despite distinct genetic and environmental contexts. We conducted a longitudinal epigenome-wide study of CKD in an African population, integrating DNA methylation and gene expression to identify epigenetic changes associated with CKD and related kidney function decline. METHODS: DNA methylation was profiled using the Illumina EPIC (850K) array in 274 Ghanaian participants from the RODAM-Prospective cohort (92 incident CKD cases and 182 matched controls), providing 548 DNA methylation observations across baseline and ∼6-year follow-up, with high-quality DNA methylation data available at both timepoints. Epigenome-wide association studies (EWAS) were performed for incident CKD, change in estimated glomerular filtration rate (ΔeGFR), and change in urinary albumin-to-creatinine ratio (ΔACR), adjusting for demographic, clinical, and technical covariates. Differentially methylated regions (DMRs) were identified using bumphunter with family-wise error rate control. Differential gene expression (RNA-seq) analyses were conducted, followed by covariate-adjusted expression quantitative trait methylation (eQTM) analyses to link methylation with gene expression. FINDINGS: At baseline, significant differentially methylated positions (DMPs) were detected at INF2 (incident CKD), CLIP4 (ΔeGFR), and TMEM109 (ΔACR), alongside DMRs at HLA-DPB1 and SH2D1B (incident CKD) and ZFP57 and OR2T11 (ΔACR). At follow-up, a progression-related DMR in C4orf39/TRIM61 (ΔACR) was identified, with recurrent signals at hypermethylated HLA-DPB1 and hypomethylated ZFP57 and OR2T11 across timepoints. Integrative eQTM analysis revealed methylation-expression associations at recurrent loci including ZFP57, HLA-DRB5, SLC39A4, and SPATC1L, with predominantly inverse associations at ZFP57, HLA-DRB5, and SLC39A4, highlighting associations with metabolic and immune regulatory pathways. INTERPRETATION: We identified epigenetic changes associated with incident CKD and kidney function decline in an African population. These methylation signals, supported by gene expression patterns, highlight immune and kidney-related pathways associated with CKD risk and progression. Our findings provide a foundation for future studies investigating the potential of epigenetic markers in CKD risk stratification and prevention in African populations. FUNDING: European Commission; European Research Council.

EBioMedicineVol. 134
University of Maryland, Baltimore (US), University of Ghana (GH), Johns Hopkins University (US), Johns Hopkins Medicine (US), Amsterdam UMC Location University of Amsterdam (NL), Korle Bu Teaching Hospital (GH), Kwame Nkrumah University of Science and Technology (GH), Amsterdam Neuroscience (NL), Amsterdam Public Health (NL), Amsterdam University Medical Centers (NL), Amsterdam Reproduction Development (NL), Amsterdam Cardiovascular Sciences (NL), Amsterdam University of Applied Sciences (NL), University of Amsterdam (NL), Walter Sisulu University (ZA)
Ernest Oppenheimer Memorial Trust
Good health and well-being
Epigenetics and DNA Methylation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon